NCT02466867View on ClinicalTrials.gov

An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

December 31, 2015

Conditions
Tinea Corporis
Interventions
DRUG

Naftin® Cream, 2% (younger pediatric cohort)

Approximately 3 grams of Naftin® Cream, 2% ist to be applied once per day for subjects aged 2 to 5 years, 11 months.

DRUG

Naftin® Cream, 2% (older pediatric cohort)

Approximately 4 grams of Naftin® Cream, 2% ist to be applied once per day for subjects aged 6 to 11 years, 11 months.

Trial Locations (3)

77845

Merz Investigative Site#001261, College Station

Unknown

Merz Investigative Site#180001, Santo Domingo

Merz Investigative Site #504001, San Pedro Sula

All Listed Sponsors
lead

Merz North America, Inc.

INDUSTRY

NCT02466867 - An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis | Biotech Hunter | Biotech Hunter